Early Fumonisin B1 Toxicity in Relation to Disrupted Sphingolipid Metabolism in Male BALB/c Mice

Journal of Biochemical and Molecular Toxicology

Volumn 12, Issue 5, 1998, Pages 281-289

  Tsunoda, Masashi ^a   Sharma, Raghubir P ^a   Riley, Ronald T ^b  

^a UNIVERSITY OF GEORGIA   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Ceramide; Fumonisin B1; Male Mice; Sphinganine; Sphingolipids; Sphingosine; Tissue Phospholipids

Indexed keywords

ANIMALIA; FUNGI; FUSARIUM; GIBBERELLA FUJIKUROI; SPHINGIODEA; ZEA MAYS;

CARBOXYLIC ACID; CARCINOGEN; CERAMIDE; DRUG DERIVATIVE; FUMONISIN; FUMONISIN B1; MYCOTOXIN; PHOSPHOLIPID; SAFINGOL; SPHINGOLIPID; SPHINGOSINE;

ANIMAL; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; BRAIN; DOSE RESPONSE; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY; LIVER; MALE; METABOLISM; MOUSE; PATHOLOGY; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; APOPTOSIS; BRAIN; CARBOXYLIC ACIDS; CARCINOGENS, ENVIRONMENTAL; CERAMIDES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; FUMONISINS; INJECTIONS, SUBCUTANEOUS; KIDNEY; LIVER; MALE; MICE; MICE, INBRED BALB C; MYCOTOXINS; PHOSPHOLIPIDS; SPHINGOLIPIDS; SPHINGOSINE;

EID: 0031635960     PISSN: 10956670     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0461(1998)12:5<281::AID-JBT4>3.0.CO;2-H     Document Type: Article

References (46)

1. 1 isolated from Fusarium moniliforme. Onderstepoort J. Vet. Res., 55, 197-203.
2. 1 in rats and mice. Natur. Toxins, 4, 16-23.
3. 1 in rats. Carcinogenesis, 12, 1247-1251.
4. E. W. Sydenham, P. G. Thiel, W. F. O. Marasas, G. S. Shepard, D. J. van Schalkwyk, and K. R. Koch (1990). Natural occurrence of some Fusarium mycotoxins in corn from low and high esophageal cancer prevalence areas of the Transkei, South Africa. J. Agric. Food Chem., 38, 1900-1903.
5. R. V. Bhat, P. H. Shetty, R. P. Amruth, and R. V. Sudarshan (1997). A foodborne disease outbreak due to the consumption of moldy sorghum and maize containing fumonisin mycotoxins. Clin. Toxicol., 35, 249-255.
6. A. H. Merrill, D. C. Liotta, and R. T. Riley (1996). Fumonisins: naturally occurring inhibitors of ceramide synthesis. Trends Cell Biol., 6, 18-223.
7. W. H. Tolleson, K. L. Dooley, W. G. Sheldon, J. D. Thurman, T. J. Bucci, and P. C. Howard (1996). The mycotoxin fumonisin induces apoptosis in cultured human cells and in livers and kidneys of rats. In, Fumonisins in Food, L. Lackson, et al., eds., pp. 237-250, Plenum Press, New York.
8. H. Wang, C. Jones, J. Ciacci-Zenella, T. Holt, D. G. Gilchrist, and M. B. Dickman (1996). Fumonisins and Alternaria alternata lycopersici toxins; sphinganine analog mycotoxins induce apoptosis in monkey kidney cells. Proc. Natl. Acad. Sci. USA, 93, 3461-3465.
9. A. H. Merrill, E.-M. Schmelz, D. L. Dillhay, S. Spiegel, J. A. Shayman, J. J. Schroeder, R. T. Riley, and E. Wang (1997). Sphingolipids - the enigmatic lipid class: biochemistry, physiology,and pathophysiology. Toxicol. Appl. Pharmacol., 142, 208-225.
10. W. P. Norred, R. D. Plattner, F. I. Meredith, and R. T. Riley (1997). Mycotoxin-induced elevation of free sphingoid bases in precision-cut rat liver slices: specificity of the response and structure-activity relationships. Toxicol. Appl. Pharmacol., 147, 63-70.
11. A. H. Merrill Jr., G. Van Ecthen, E. Wang, and K. Sandhoff (1993). Fumonisin inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ. J. Biol. Chem., 268, 27299-27306.
12. E. Wang, W. P. Norred, C. W. Bacon, R. T. Riley, and A. H. Merrill (1991). Inhibition of sphingosine biosynthesis by fumonisins. J. Biol. Chem., 266, 14486-14490.
13. R. Harel and A. H. Futerman (1993). Inhibition of sphingolipid synthesis affects axonal outgrowth in cultured hippocampal neurons. J. Biol. Chem., 268, 14476-14481.
14. 1. A molecular mechanism for carcinogenesis associated with Fusarium moniliforme. J. Biol. Chem., 269, 3475-3481.
15. H. S. Yoo, W. P. Norred, J. Showker, and R. T. Riley (1996). Elevated sphingoid bases and complex sphingolipid depletion as contributing factors in fumonisin-induced toxicity. Toxicol. Appl. Pharmacol., 138, 211-218.
16. 1 in human keratinocytes, fibroblasts, oesophageal epithelial cells and hepatoma cells. Carcinogenesis, 17, 239-249.
17. 1 in B6C3F1 mice and Fischer 344 rats. Fund. Appl. Toxicol., 24, 102-110.
18. 1. J. Comp. Pathol., 117, 371-381.
19. R. T. Riley, E. Wang, and A. H. Merrill Jr. (1994). Liquid chromatographic determination of sphinganine and sphingosine: use of the free sphinganine-to-sphingosine ratio as a biomarker for consumption of fumonisins. J. AOAC, 77, 533-540.
20. A. H. Merrill, E. Wang, R. E. Mullins, W. C. Jamison, S. Nimkar, and D. C. Liotta (1988). Quantitation of free sphingosine in liver by high performance liquid chromatography. Anal. Biochem., 171, 373-381.
21. R. C. Gaver and C. C. Sweeley (1965). Methods for methanolysis of sphingolipids and direct determination of long-chain bases by gas chromatography. J. Am. Oil Chem. Soc., 42, 294-298.
22. S. Jayadev, C. M. Linardic, and Y. A. Hannun (1994). Identification of arachidonic acid as a mediator of sphingomyelin hydrolysis in response to tumor necrosis factor α. J. Biol. Chem., 269, 5757-5763.
23. Valdhoven and G. P. Mennearts (1987). Inorganic phosphate measurements in the nanomolar range. Anal. Biochem., 161, 45-48.
24. R. Gold, M. Schmied, G. Giegrich, H. Breitschopf, H. P. Hartung, K. V. Toyka, and H. Lassman (1994). Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation technique. Lab. Invest., 71, 219-225.
25. R. T. Riley, E. Wang, J. J. Schroeder, E. R. Smith, R. D. Plattner, H. Abbas, H.-S. Yoo, and A. H. Merrill Jr. (1996). Evidence for disruption of sphingolipid metabolism as a contributing factor in the toxicity and carcinogenicity of fumonisins. Nat. Toxins, 4, 3-15.
26. 1. Mycopathologia, 130, 163-170.
27. 1 induces disruption of sphingolipid metabolism in Sprague-Dawley rats: a new mechanism of nephrotoxicity. J. Nutr., 124, 594-603.
28. R. T. Riley, N.-H. An, J. L. Showker, H.-S. Yoo, W. P. Norred, W. J. Chamberlain, E. Wang, A. H. Merrill Jr., G. Motelin, V. R. Beasley, and W. M. Haschek (1993). Alteration of tissue and serum sphinganine to sphingosine ratio: an early marker of exposure to fumonisin-containing feeds in pigs. Toxicol. Appl. Pharmacol., 118, 105-112.
29. E. Wang, F. Ross, T. M. Wilson, R. T. Riley, and A. H. Merrill Jr. (1992). Increases in serum sphingosine and sphinganine and decreases in complex sphingolipids in ponies given feed containing fumonisins, mycotoxins produced by Fusarium moniliforme. J. Nutr., 122, 1706-1716.
30. 3. Environ. Toxicol. Pharmacol., 3, 221-228.
31. 1. Environ. Toxicol. Pharmacol., 5, 101-104.
32. 1 on sphingoid base elevations in precision-cut rat liver and kidney slices. Toxicol. In Vitro, 10, 349-358.
33. 1 on protein and lipid synthesis in primary rat hepatocytes. Food Chem. Toxicol., 34, 361-369.
34. 1 in male Sprague-Dawley rats. Natur. Toxin., 1, 341-346.
35. 1 toxicity. J. Pharmacol. Exp. Therap. 285, 317-324.
36. B. G. Darney and B. B. Agarwal (1997). Early events in TNF signaling: a story of associations and dissociations. J. Leucocyt. Biol., 61, 559-566.
37. R. N. Kolesnick and D. W. Golde (1994). The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell, 77, 325-328.
38. W. D. Jarvis, F. A. Fornari Jr., R. A. Traylor, H. A. Martin, L. B. Kramer, R. K. Erukulla, R. Bittman, and S. Grant (1996). Induction of apoptosis and potentiation of ceramide-mediated cytotoxicity by sphingoid bases in human myeloid leukemia cells. J. Biol. Chem., 271, 8275-8284.
39. G. S. Dbaibo, L. M. Obeid, and Y. A. Hunnan (1993). Tumor necrosis factor-α (TNF-α) signal transduction through ceramide: dissociation of growth inhibitory effects of TNF-α from activation of nuclear factor-κB. J. Biol. Chem., 268, 17762-17766.
40. J. Turinsky, B. P. Bayly, and D. M. O'Sullivan (1990). 1,2-Diacylglycerol and ceramide levels in rat skeletal muscle and liver in vivo. J. Biol. Chem., 265, 7933-7938.
41. 1 on phosphatidylethanolamine biosynthesis in Chinese hamster ovary cells. Biochim. Biophys. Acta, 1304, 190-196.
42. E. R. Smith and A. H. Merrill Jr. (1995). Differential roles of de novo sphingolipid biosynthesis and turnover in the burst of free sphingosine and sphinganine, and their 1-phosphates and N-acyl-derivatives, that occurs upon changing the medium of cells in culture. J. Biol. Chem., 270, 18749-18758.
43. A. G. Uren and D. L. Vaux (1996). Molecular and clinical aspects of apoptosis. Pharmacol. Ther., 72, 37-50.
44. S. J. Chmura, E. Nodzenski, R. R. Weichselbaum, and J. Quintans (1996). Protein kinase C inhibition induces apoptosis and ceramide production through activation of neutral sphingomyelinase. Cancer Res., 56, 2711-2714.
45. C. X. Huang, M. Dickman, G. Henderson, and C. Jones (1995). Repression of protein-kinase C and stimulation of cyclic AMP response elements by fumonisin, a fungal encoded toxin which is a carcinogen. Cancer Res., 55, 1655-1659.
46. Y. A. Hannun and R. M. Bell (1987). Lysosphingolipids inhibit protein kinase C: implications for the sphingolipidase. Science, 235, 500-507.